Vivos Therapeutics, Inc. VVOS 深 沪
等待开盘 02-07 09:30:00 美东时间
1.55
+0.050
+3.33%
华盛通- 最 高1.5796
- 今 开1.50
- 成交量 8.66万股
- 最 低 1.47
- 昨 收 1.50
- 总市值 1770.12万
- 52周最高 7.95
- 市盈率 静 --
- 换手率 0.76%
- 52周最低 1.4235
- 委 比 26.47%
- 总股本 1142.01万
- 历史最高 360.25
- 量 比 0.63
- 振 幅 7.31%
- 历史最低 1.4235
- 每 手 1
- 风险率 1.09%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Vivos Therapeutics Appoints Gregg Johnson to Board
An announcement from Vivos Therapeutics ( ($VVOS) ) is now available. Effective...
今天 05:38
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Quarter
The most oversold stocks in the health care sector presents an opportunity to b...
02-03 19:23
Vivos Therapeutics shares are trading lower after the company announced the exercise of warrants generating $4.64 million in gross proceeds.
Vivos Therapeutics shares are trading lower after the company announced the exe...
01-16 21:02
Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds
Vivos Therapeutics, Inc. (VVOS) has entered into a definitive agreement to exercise outstanding warrants to purchase up to 1,982,356 shares at a reduced exercise price of $2.34 per share, generating approximately $4.64 million in gross proceeds. The company will issue new warrants for 3,964,712 shares at $2.09 per share, with varying expiration terms. The offering is expected to close on January 20, 2026, with proceeds used for working capital an...
01-16 13:00
Vivos Therapeutics to Participate in Online Fireside Chat with Water Tower Research on December 16, 2025, at 11 am EST
Vivos Therapeutics, Inc. (NASDAQ: VVOS) announced that CEO Kirk Huntsman and CFO Brad Amman will participate in a fireside chat on December 16, 2025, at 11:00 am ET with Robert Sassoon of Water Tower Research. The discussion will cover Vivos' strategic business model pivot, operational execution, market opportunity, competitive environment, growth, and financial strategies. The event is listen-only and available for registration at www.globenewsw...
2025-12-15 22:30
Vivos Therapeutics Secures $2M Note with Avondale
Vivos Therapeutics ( ($VVOS) ) has provided an announcement. On December 5, 202...
2025-12-06 06:28
美股大行评级 | 美鹰服饰、CrowdStrike、迈威尔科技获多家机构上调目标价；ACHC、GitLab、Okta遭多家机构下调目标价
今日重点评级关注：Guggenheim：维持Cybin Inc. Common Shares"买入"评级，目标价从39美元升至48美元；HC Wainwright & Co.：维持Capricor Therapeutics"买入"评级，目标价从24美元升至60美元
2025-12-04 09:38
Ascendiant Capital Maintains Buy on Vivos Therapeutics, Lowers Price Target to $5.5
Ascendiant Capital analyst Lucas Ward maintains Vivos Therapeutics (NASDAQ:VVOS) with a Buy and lowers the price target from $6.5 to $5.5.
2025-12-03 19:47
Vivos Therapeutics Q3 EPS $(0.49) Misses $(0.41) Estimate, Sales $6.783M Beat $4.686M Estimate
Vivos Therapeutics (NASDAQ:VVOS) reported quarterly losses of $(0.49) per share which missed the analyst consensus estimate of $(0.41) by 18.07 percent. This is a 22.5 percent decrease over losses of $(0.40) per share
2025-11-20 05:08
美股大行评级 | Stifel上调特斯拉目标价升至508美元；多家大行上调Vita Coco目标价最高至58美元
今日重点评级关注：HC Wainwright & Co.：维持Oncolytics Biotech"买入"评级，目标价从5美元升至10美元；HC Wainwright & Co.：维持Barinthus Biotherapeutics"买入"评级，目标价从3美元升至4美元
2025-11-18 15:28
